eRAPID: Online Symptom Reporting in Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

July 31, 2023

Study Completion Date

December 31, 2023

Conditions
Thoracic CancerNon-small Cell Lung CancerSmall-cell Lung CancerPleural Mesothelioma
Interventions
OTHER

eRAPID online symptom monitoring in lung cancer

The eRAPID in lung cancer intervention is an online symptom monitoring system which provides tailored advice depending on the severity of symptoms reported. The system is integrated into the electronic medical record and results can be viewed by the medical team.

Trial Locations (1)

LS9 7TF

St James's University Hospital, Leeds Teaching Hospital Trust, Leeds

All Listed Sponsors
collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

collaborator

Iqvia Pty Ltd

INDUSTRY

lead

University of Leeds

OTHER

NCT04324437 - eRAPID: Online Symptom Reporting in Lung Cancer | Biotech Hunter | Biotech Hunter